SNORA71A knockdown in HT-29 cells led to significant inhibition of cell migration and invasion ability, which targeted LBP to participate in NAFLD in colorectal cancer cells [39]. The gene discussed is LBP; the disease is metabolic dysfunction-associated steatotic liver disease.